tiprankstipranks
Advertisement
Advertisement

GB:AZN Stock Latest News

Ionis, AstraZeneca ATTR-CM trial did not meet primary endpoint
The FlyIonis, AstraZeneca ATTR-CM trial did not meet primary endpoint
13h ago
AZN
ALNY
Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data
PremiumThe Fly
Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data
13h ago
AZN
ALNY
Oppenheimer biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Oppenheimer biotech analysts hold an analyst/industry conference call
1d ago
AZN
IONS
AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial
PremiumCompany Announcements
AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial
1d ago
AZN
AstraZeneca Advances Off‑the‑Shelf CAR‑T Program in Tough‑to‑Treat Multiple Myeloma
PremiumCompany Announcements
AstraZeneca Advances Off‑the‑Shelf CAR‑T Program in Tough‑to‑Treat Multiple Myeloma
1d ago
AZN
AstraZeneca’s CREW Study: Real-World Tezspire Data That Could Shape Respiratory Revenues
PremiumCompany AnnouncementsAstraZeneca’s CREW Study: Real-World Tezspire Data That Could Shape Respiratory Revenues
1d ago
AZN
Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements
Premium
The Fly
Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements
2d ago
AZN
AMGN
Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints
Premium
The Fly
Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints
2d ago
AZN
AMGN
AstraZeneca’s Tezspire Hits Key Phase III Goals in Eosinophilic Esophagitis
PremiumCompany Announcements
AstraZeneca’s Tezspire Hits Key Phase III Goals in Eosinophilic Esophagitis
2d ago
AZN
AstraZeneca Explores Eye Imaging to Spot Hidden Heart Disease: What Investors Should Watch
PremiumCompany Announcements
AstraZeneca Explores Eye Imaging to Spot Hidden Heart Disease: What Investors Should Watch
2d ago
AZN
AstraZeneca, Daiichi’s TROPION-Urothelial04 phase 3 trial of Datroway initiated
PremiumThe Fly
AstraZeneca, Daiichi’s TROPION-Urothelial04 phase 3 trial of Datroway initiated
3d ago
AZN
AstraZeneca Deepens Its Type 2 Diabetes Pipeline With New Global Patient Mapping Study
PremiumCompany Announcements
AstraZeneca Deepens Its Type 2 Diabetes Pipeline With New Global Patient Mapping Study
3d ago
AZN
AstraZeneca Prices €2.55 Billion Eurobond to Support Long-Term Funding Strategy
PremiumCompany AnnouncementsAstraZeneca Prices €2.55 Billion Eurobond to Support Long-Term Funding Strategy
4d ago
AZN
AstraZeneca’s AZD4144 Interaction Study Adds Quiet Support to AZN’s Pipeline Story
Premium
Company Announcements
AstraZeneca’s AZD4144 Interaction Study Adds Quiet Support to AZN’s Pipeline Story
4d ago
AZN
AstraZeneca initiated with an Outperform at CICC
Premium
The Fly
AstraZeneca initiated with an Outperform at CICC
5d ago
AZN
AstraZeneca initiated with an Outperform at CICC
PremiumThe Fly
AstraZeneca initiated with an Outperform at CICC
5d ago
AZN
AstraZeneca’s EMBOLD-Asia Trial Signals Fresh Push Into Obesity Market
PremiumCompany Announcements
AstraZeneca’s EMBOLD-Asia Trial Signals Fresh Push Into Obesity Market
8d ago
AZN
AstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors
PremiumCompany Announcements
AstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors
8d ago
AZN
AstraZeneca Expands Respiratory Pipeline With New China Trial for Chronic Lung Infections
PremiumCompany Announcements
AstraZeneca Expands Respiratory Pipeline With New China Trial for Chronic Lung Infections
9d ago
AZN
AstraZeneca CFO Receives First Vesting Under Long-Term Performance Share Plan
PremiumCompany AnnouncementsAstraZeneca CFO Receives First Vesting Under Long-Term Performance Share Plan
10d ago
AZN
AstraZeneca Tracks Real‑World Ultomiris Outcomes in Polish Rare Disease Study
Premium
Company Announcements
AstraZeneca Tracks Real‑World Ultomiris Outcomes in Polish Rare Disease Study
10d ago
AZN
AstraZeneca to discontinue eVOLVE-Lung02 Phase III trial
Premium
The Fly
AstraZeneca to discontinue eVOLVE-Lung02 Phase III trial
12d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >